[{"type": "title", "data": "SUS Pharmaceutical Alternatives - HYDROmorphone (DILAUDID BRAND) Tablet Patient Self Adminiistration"}, {"type": "category", "data": "Admit/Transfer/Discharge"}, {"type": "note", "data": "Restricted to Addiction Medicine Service for prescribing pharmaceutical alternative HYDROmorphone tablets for patient self-administration. Pharmaceutical alternative orders will be rejected unless ordered by an approved prescriber", "value": ""}, {"type": "category", "data": "Patient Care"}, {"type": "order", "data": "Communication Order", "value": "checked"}, {"type": "sentence", "data": "Provide harm reduction supplies for safer injecting, including Sterifilt filters"}, {"type": "order", "data": "Insert Peripheral IV (Intravenous) Catheter\u00a0", "value": ""}, {"type": "sentence", "data": "T;N"}, {"type": "category", "data": "Medications"}, {"type": "note", "data": "Obtain patient consent and ensure the patient understands the treatment agreement regarding what they are giving consent to and has the opportunity to ask questions prior to signing the consent form", "value": ""}, {"type": "note", "data": "Alert patient's community pharmacy of hospitalization and consider discontinuation of community pharmaceutical alternative(s)", "value": ""}, {"type": "note", "data": "Review active HYDROmorphone orders and discontinue if appropriate", "value": ""}, {"type": "note", "data": "Provider to indicate \"dispense quantity\" and \"first dose start\" in order comment", "value": ""}, {"type": "note", "data": "Maximum 112 mg / day (8 mg x 14 tablets)", "value": ""}, {"type": "order", "data": "HYDROmorphone (DILAUDID BRAND) 8 mg tab (prototype)", "value": "checked"}, {"type": "sentence", "data": "tab, PO, qdaily, drug form: tab, Dispense Take Home Medication"}, {"type": "order", "data": "naloxone 0.4 mg/mL kit", "value": ""}, {"type": "sentence", "data": "1 kit, IM, once, drug form: kit, Dispense Take Home Medication, Dispense qty: 1 kit"}, {"type": "order", "data": "naloxone", "value": "checked"}, {"type": "sentence", "data": "0.1 mg, IV, q2min, PRN reverse opioid effect, drug form: inj"}, {"type": "sentence", "data": "0.4 mg, IV, q2min, PRN reverse opioid effect, drug form: inj"}, {"type": "order", "data": "naloxone", "value": "checked"}, {"type": "sentence", "data": "0.1 mg, IM, q2min, PRN reverse opioid effect, drug form: inj"}, {"type": "sentence", "data": "0.4 mg, IM, q2min, PRN reverse opioid effect, drug form: inj"}, {"type": "category", "data": "Laboratory"}, {"type": "order", "data": "Creatinine and EGFR", "value": ""}, {"type": "sentence", "data": "Blood, Routine, Collection: T;N, once"}, {"type": "order", "data": "Electrolytes Panel (Na, K, Cl, CO2, Anion Gap)", "value": ""}, {"type": "sentence", "data": "Blood, Routine, Collection: T;N, once"}, {"type": "order", "data": "Liver Panel (Bilirubin, ALP, Alb, ALT, GGT)", "value": ""}, {"type": "sentence", "data": "Blood, Routine, Collection: T;N, once"}, {"type": "order", "data": "HCG Quantitative Blood", "value": ""}, {"type": "sentence", "data": "Blood, Routine, Collection: T;N, once"}, {"type": "order", "data": "Drug Screen Urine", "value": ""}, {"type": "sentence", "data": "Urine, Routine, Unit collect, Collection: T;N, once"}, {"type": "order", "data": "Drug Screen Urine", "value": ""}, {"type": "sentence", "data": "Urine, Routine, Unit collect, Collection: T;N, qweek"}, {"type": "category", "data": "Consults/Referrals"}, {"type": "note", "data": "Alert AMCT Liaison Nurse (through switchboard) that patient is being prescribed HYDROmorphone (DILAUDID) tablets for self-administration to add to their list for ongoing patient follow-up and nursing staff support.", "value": ""}]
